Sign Up to like & get
recommendations!
0
Published in 2020 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noaa222.719
Abstract: Abstract BACKGROUND Despite poor clinical outcomes, no targeted therapies have been established for the treatment of Adamantinomatous Craniopharyngioma (ACP). The only known genetic aberration is a mutation in CTNNB1 that results in the nuclear accumulation…
read more here.
Keywords:
acp cyst;
emt;
cyst fluid;
pathology ... See more keywords